112 related articles for article (PubMed ID: 7560253)
1. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.
Hinderling PH; Tendolkar A; Dee CM; Barr WH; Seiberling M; Duerr H
J Clin Pharmacol; 1995 Jul; 35(7):721-9. PubMed ID: 7560253
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
Wagner F; Jähnchen E; Trenk D
Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
Greenberg S; Cantor E; Paul J
J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
[TBL] [Abstract][Full Text] [Related]
4. Propafenone shows class Ic and class II antiarrhythmic effects.
Stoschitzky K; Stoschitzky G; Lercher P; Brussee H; Lamprecht G; Lindner W
Europace; 2016 Apr; 18(4):568-71. PubMed ID: 26056191
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
Nanoff C; Schütz W
J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
Trenk D; Wagner F; Sachs W; Jähnchen E
Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
[TBL] [Abstract][Full Text] [Related]
8. Influence of the new class I antiarrhythmic agent diprafenone on the end-systolic pressure-volume relationship (conductance technique).
Thormann J; Kramer W; Kremer P; Schlepper M
Cardiovasc Drugs Ther; 1989 Apr; 3(2):145-54. PubMed ID: 2487530
[TBL] [Abstract][Full Text] [Related]
9. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart.
Groschner K; Lindner W; Schnedl H; Kukovetz WR
Br J Pharmacol; 1991 Mar; 102(3):669-74. PubMed ID: 1364837
[TBL] [Abstract][Full Text] [Related]
10. Influence of food on the bioavailability and some pharmacokinetic parameters of diprafenone--a novel antiarrhythmic agent.
Koytchev R; Alken RG; Mayer O; Smith I; Greenwood M
Eur J Clin Pharmacol; 1996; 50(4):315-9. PubMed ID: 8803526
[TBL] [Abstract][Full Text] [Related]
11. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
Geibel A; Zehender M; Hohnloser S; Landsrath C; Meinertz T; Just H
Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
[TBL] [Abstract][Full Text] [Related]
12. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
Gülker H; Heuer H; Thale J; Behrenbeck T
Z Kardiol; 1987 Jul; 76(7):411-4. PubMed ID: 3673162
[TBL] [Abstract][Full Text] [Related]
13. Effect of diprafenone on the pharmacokinetics of digoxin.
Koytchev R; Alken RG; Mayer O
Eur J Clin Pharmacol; 1996; 50(1-2):97-100. PubMed ID: 8739818
[TBL] [Abstract][Full Text] [Related]
14. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
Zhong D; Blume H
Pharmazie; 1994 Jan; 49(1):38-41. PubMed ID: 8140128
[TBL] [Abstract][Full Text] [Related]
15. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
Wellstein A; Palm D; Pitschner HF; Belz GG
Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective determination of diprafenone in human plasma.
Zhong D; Chen R; Fieger-Büschges H; Blume H
Pharmazie; 1997 Feb; 52(2):106-9. PubMed ID: 9122271
[TBL] [Abstract][Full Text] [Related]
17. Concentration-effect relations of 5-hydroxypropafenone in normal subjects.
Haefeli WE; Vozeh S; Ha HR; Taeschner W; Follath F
Am J Cardiol; 1991 May; 67(11):1022-6. PubMed ID: 2018005
[TBL] [Abstract][Full Text] [Related]
18. Block of single cardiac Na+ channels by antiarrhythmic drugs: the effect of amiodarone, propafenone and diprafenone.
Kohlhardt M; Fichtner H
J Membr Biol; 1988 May; 102(2):105-19. PubMed ID: 2458471
[TBL] [Abstract][Full Text] [Related]
19. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man.
Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C
J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126
[TBL] [Abstract][Full Text] [Related]
20. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
